Inovelon
Inovelon is a medicine authorised by Swissmedic under authorisation number 62066. The authorisation holder is Eisai Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 June 2012 and the authorisation is valid without a time limit. ATC code N03AF03 places the medicine in the group Antiepileptics.
| Authorisation number | 62066 |
|---|---|
| Name | Inovelon |
| Full name | Inovelon, Suspension zum Einnehmen |
| Authorisation holder | Eisai Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AF03 |
| First authorisation | 13 June 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Inovelon, Suspension zum Einnehmen | B | 13 June 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 460 | ml | N03AF03 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Inovelon authorised in Switzerland?
Yes. Inovelon is authorised by Swissmedic under authorisation number 62066, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Inovelon have?
Inovelon is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Inovelon?
The authorisation holder is Eisai Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.